ESR1 and cancer: Estrogen replacement therapy/hormone replacement therapy (ERT/HRT) presents an alternative but is associated with significant risks, such as cerebrovascular accidents and malignant tumors, leading to the exploration of selective estrogen receptor modulators (SERMs) as safer alternatives.